{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:30:22Z","timestamp":1790400622697,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Consumer Healthcare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s12325-018-0792-z","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T15:30:01Z","timestamp":1537889401000},"page":"2024-2040","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14\u00a0Days of Esomeprazole Treatment"],"prefix":"10.1007","volume":"35","author":[{"given":"Philip B.","family":"Miner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip O.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio C.","family":"Gatoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"issue":"3","key":"792_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.phrs.2008.09.016","volume":"59","author":"V Savarino","year":"2009","unstructured":"Savarino V, Di Mario F, Scarpignato C. Proton pump inhibitors in GORD: an overview of their pharmacology, efficacy and safety. Pharmacol Res. 2009;59(3):135\u201353.","journal-title":"Pharmacol Res"},{"issue":"3","key":"792_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ajg.2012.444","volume":"108","author":"PO Katz","year":"2013","unstructured":"Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308\u201328.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"792_CR3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/0016-5085(92)90017-S","volume":"103","author":"S Fiorucci","year":"1992","unstructured":"Fiorucci S, Santucci L, Chiucchiu S, Morelli A. Gastric acidity and gastroesophageal reflux patterns in patients with esophagitis. Gastroenterology. 1992;103(3):855\u201361.","journal-title":"Gastroenterology"},{"issue":"5","key":"792_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1023\/A:1015009300955","volume":"47","author":"K Rohss","year":"2002","unstructured":"Rohss K, Hasselgren G, Hedenstrom H. Effect of esomeprazole 40\u00a0mg vs omeprazole 40\u00a0mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease. Dig Dis Sci. 2002;47(5):954\u20138.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"792_CR5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S1590-8658(00)80326-6","volume":"32","author":"MT Franco","year":"2000","unstructured":"Franco MT, Salvia G, Terrin G, et al. Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood. Dig Liver Dis. 2000;32(8):660\u20136.","journal-title":"Dig Liver Dis"},{"issue":"6","key":"792_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1046\/j.1365-2036.2000.00775.x","volume":"14","author":"PO Katz","year":"2000","unstructured":"Katz PO, Hatlebakk JG, Castell DO. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole. Aliment Pharmacol Ther. 2000;14(6):709\u201314.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"792_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000200917","volume":"51","author":"NJ Bell","year":"1992","unstructured":"Bell NJ, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion. 1992;51(Suppl 1):59\u201367.","journal-title":"Digestion"},{"issue":"4","key":"792_CR8","first-page":"576","volume":"92","author":"J Labenz","year":"1997","unstructured":"Labenz J, Tillenburg B, Peitz U, et al. Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients. Am J Gastroenterol. 1997;92(4):576\u201381.","journal-title":"Am J Gastroenterol"},{"key":"792_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev.pa.35.040195.001425","volume":"35","author":"G Sachs","year":"1995","unstructured":"Sachs G, Shin JM, Briving C, Wallmark B, Hersey S. The pharmacology of the gastric acid pump: the H+,K+ ATPase. Annu Rev Pharmacol Toxicol. 1995;35:277\u2013305.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"10","key":"792_CR10","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1046\/j.1365-2036.2001.01087.x","volume":"15","author":"T Andersson","year":"2001","unstructured":"Andersson T, Rohss K, Bredberg E, Hassan-Alin M. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole. Aliment Pharmacol Ther. 2001;15(10):1563\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"792_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1365-2036.2006.03235.x","volume":"25","author":"PO Katz","year":"2007","unstructured":"Katz PO, Ginsberg GG, Hoyle PE, Sostek MB, Monyak JT, Silberg DG. Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis. Aliment Pharmacol Ther. 2007;25(5):617\u201328.","journal-title":"Aliment Pharmacol Ther"},{"issue":"suppl 1","key":"792_CR12","doi-asserted-by":"publisher","first-page":"A49","DOI":"10.1016\/S0016-5085(98)80199-6","volume":"114","author":"I Wiklund","year":"1998","unstructured":"Wiklund I, Junghard O, Grace E, et al. Quality of life in reflux and dyspepsia. Development and psychometric documentation of a disease-specific questionnaire (QOLRAD) (abstract G0199). Gastroenterology. 1998;114(suppl 1):A49.","journal-title":"Gastroenterology"},{"issue":"7","key":"792_CR13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/MCG.0b013e3181dd9c5b","volume":"44","author":"DA Johnson","year":"2010","unstructured":"Johnson DA, Katz PO, Levine D, et al. Prevention of relapse of healed reflux esophagitis is related to the duration of intragastric pH\u2009>\u20094. J Clin Gastroenterol. 2010;44(7):475\u20138.","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"792_CR14","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/gutjnl-2013-304883","volume":"63","author":"PJ Kahrilas","year":"2014","unstructured":"Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW. Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy. Gut. 2014;63(5):720\u20136.","journal-title":"Gut"},{"issue":"5","key":"792_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/gut.31.5.509","volume":"31","author":"TC Dehn","year":"1990","unstructured":"Dehn TC, Shepherd HA, Colin-Jones D, Kettlewell MG, Carroll NJ. Double blind comparison of omeprazole (40\u00a0mg od) versus cimetidine (400\u00a0mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24\u00a0h pH monitoring. Gut. 1990;31(5):509\u201313.","journal-title":"Gut"},{"issue":"7","key":"792_CR16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1046\/j.1365-2036.2000.00813.x","volume":"14","author":"T Lind","year":"2000","unstructured":"Lind T, Rydberg L, Kyleback A, et al. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2000;14(7):861\u20137.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"792_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00044011-200424010-00001","volume":"24","author":"K Rohss","year":"2004","unstructured":"Rohss K, Wilder-Smith C, Naucler E, Jansson L. Esomeprazole 20\u00a0mg provides more effective intragastric acid control than maintenance-dose rabeprazole, lansoprazole or pantoprazole in healthy volunteers. Clin Drug Investig. 2004;24(1):1\u20137.","journal-title":"Clin Drug Investig"},{"issue":"6","key":"792_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2165\/00044011-200828060-00001","volume":"28","author":"C Wilder-Smith","year":"2008","unstructured":"Wilder-Smith C, Backlund A, Eckerwall G, Lind T, Fjellman M, Rohss K. Effect of increasing esomeprazole and pantoprazole doses on acid control in patients with symptoms of gastro-oesophageal reflux disease: a randomized, dose-response study. Clin Drug Investig. 2008;28(6):333\u201343.","journal-title":"Clin Drug Investig"},{"issue":"2","key":"792_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/00365520601075845","volume":"42","author":"C Wilder-Smith","year":"2007","unstructured":"Wilder-Smith C, Lind T, Lundin C, Naucler E, Nilsson-Pieschl C, Rohss K. Acid control with esomeprazole and lansoprazole: a comparative dose-response study. Scand J Gastroenterol. 2007;42(2):157\u201364.","journal-title":"Scand J Gastroenterol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-018-0792-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-018-0792-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-018-0792-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:34:39Z","timestamp":1724412879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-018-0792-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["792"],"URL":"https:\/\/doi.org\/10.1007\/s12325-018-0792-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"assertion":[{"value":"8 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}